Characterization of the Analgesic Effect of CBD in Healthy, Normal Volunteers
Status:
Completed
Trial end date:
2020-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this double-blind, placebo-controlled study is to determine the analgesic
effects of cannabidiol (CBD), a chemical constituent found in cannabis that does not have
intoxicating effects. The analgesic effects of CBD will be assessed using the Cold-Pressor
Test (CPT), a laboratory model of pain which has predictive validity for the clinical use of
analgesics.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
New York State Psychiatric Institute University of California, Los Angeles